Translate

Saturday, August 17, 2013

Medical Marijuana: Where the Discussion Collides


By Alexandra D. Datig

I have often said there is a place for medical marijuana if a pharmaceutical approach can be found that is safe and effective.  I have also  never been against aiding the dying or those who suffer from debilitating illnesses and are desperate to find relief for his or her pain.  For some reason, however, when I speak in support of that argument, I feel like I am baited into a different discussion. 

My friend Roger Morgan, founder of the Take Back AmericaCampaign, explained in a correspondence earlier today, that in the late 1970’s the term "medical marijuana" was coined by Keith Stroup, founder of NORML, as a red herring to give marijuana a good name as a first step towards full legalization.

Although the FDA’s scheduling process list marijuana as a schedule one drug, seen as having no medicinal value, this may not necessarily be the case.  Over the past decade, we have learned that there are in fact medical properties in marijuana that do show promise in children that use CBD, also called cannabidiol, for a variety of central nervous system disorders.   CBDs are the non-psychoactive ingredient in marijuana, meaning they do not cause the user to get high.  

According to my friend Roger Morgan who is a world-renowned drug prevention expert, marijuana is comprised of 483 chemicals that turn into 2,000 when smoked, and 61 cannabinoids.  Of the 61 cannabinoids, only one isolated cannabinoid, appears to have medicinal value.  The problem is with the other 60, and their chemicals, which are known to cause brain damage, mental illness, birth defects, addiction and myriad of health problems.  

GW Pharmaceuticals created a medical grade marijuana known as Sativex based on the science of CBD research, which was approved by the United Kingdom version of the FDA and is available in England by prescription.  Sativex, which is an oil-based, mint flavored oral spray, has yet to pass the scrutiny test with the FDA because marijuana’s efficacy is unreliable thus far and does not meet the standards of the FDA.  On the flip side, while Sativex is going through the FDA’s clinical trails, marijuana profiteers and unethical marijuana doctors are making millions off of crude, toxin exposed, highly potent and untested as well as unregulated so-called medical marijuana because it is seen by many as a free for all to get high.  Ironically, none of these snake oil salesmen can tell an inexperienced user which strain or which THC potency is the right one to use.  The question is, what will this experiment of public fraud eventually cost in terms of long-term health consequences and harms?

I think we’re far away from being able to find common ground on what is reasonable and most of all what is safe when evaluating the arguments about marijuana.  We also know that marijuana advocates aren’t wasting any time and have engineered a deliberately misleading clash in their dialogue by promoting recreational use through the guise of medicine.  One example of this was Montell Williams who was recently on Piers Morgan.  If the medical marijuana establishment has done one thing in terms of educating the public about marijuana, it has sent the message that medical marijuana is the back door for marijuana abuse through contrived non-medical purposes.  As for the research on CBDs, I agree with my friend Roger Morgan who says hopefully research should never stop trying to perfect it for whatever therapeutic value it may have.